Literature DB >> 1959156

Measles antibody prevalence after mass immunization in São Paulo, Brazil.

C S Pannuti1, J C Moraes, V A Souza, M C Camargo, N T Hidalgo.   

Abstract

In 1987, a mass immunization campaign against measles was carried out in the greater metropolitan region of São Paulo, Brazil. During a ten-day period, 4,194,174 children from 9 months to 14 years old, representing 86% of the target population, were vaccinated regardless of their previous vaccination status. Four months later, the prevalence of measles antibodies was evaluated through a random seroepidemiological survey. The survey included all children in greater São Paulo between one month and 14 years old, irrespective of campaign participation. Blood samples were collected on filter-paper and tested for measles antibody by indirect immunofluorescence. Negative or doubtful cases were tested again using an immunoenzymatic assay (ELISA). Of the 8661 samples included in the study, 8146 (94.1%) were positive for measles antibody. In children aged one year or more a significant difference in antibody prevalence was observed when comparing those who were vaccinated during the mass immunization (98.0%) with those who did not participate in the campaign (91.3%). In addition, after the immunization, a marked and immediate decrease was observed in incidence rates for measles cases notified to the State Secretary of Health, falling from 222/100,000 inhabitants in 1987 to 2.7/100,000 in 1988. These data suggest that mass immunization can serve as an additional strategy for the rapid control of measles in developing countries.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1959156      PMCID: PMC2393258     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  4 in total

1.  Enzyme-linked immunosorbent assay (ELISA) for measles antibody. A comparison with haemagglutination inhibition, immunofluorescence and plaque neutralization tests.

Authors:  V A de Souza; C S Pannuti; L M Sumita; P Albrecht
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1991 Jan-Feb       Impact factor: 1.846

2.  Comparison of indirect immunofluorescence test for measles antibodies with haemagglutination inhibition and plaque neutralization tests.

Authors:  V A de Souza; C S Pannuti; C V de Godoy; P Albrecht; M H Lopes; J da S Mendonça
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1990 Sep-Oct       Impact factor: 1.846

3.  The use of filter paper blood smears in a practical fluorescent test for American Trypanosomiasis serodiagnosis.

Authors:  S L de Souza; M E Camargo
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1966 Nov-Dec       Impact factor: 1.846

4.  Enzyme-linked immunosorbent assay for evaluation of immunity to measles virus.

Authors:  K A Weigle; M D Murphy; P A Brunell
Journal:  J Clin Microbiol       Date:  1984-03       Impact factor: 5.948

  4 in total
  5 in total

1.  Measles outbreak response decision-making under uncertainty: a retrospective analysis.

Authors:  Christopher J Fonnesbeck; Katriona Shea; Spencer Carran; Jose Cassio de Moraes; Christopher Gregory; James L Goodson; Matthew J Ferrari
Journal:  J R Soc Interface       Date:  2018-03       Impact factor: 4.118

2.  Ideal age for measles vaccination with persisting maternal antibody, human immunodeficiency virus infection and protein-calorie malnutrition.

Authors:  S C Arya
Journal:  Infection       Date:  1993 Jul-Aug       Impact factor: 3.553

3.  A model-based design of a vaccination strategy against rubella in a non-immunized community of São Paulo State, Brazil.

Authors:  E Massad; M N Burattini; R S de Azevedo Neto; H M Yang; F A Coutinho; D M Zanetta
Journal:  Epidemiol Infect       Date:  1994-06       Impact factor: 2.451

4.  Pulse mass measles vaccination across age cohorts.

Authors:  Z Agur; L Cojocaru; G Mazor; R M Anderson; Y L Danon
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

5.  Measles on the Rise: The importance of vaccination.

Authors:  Elias A Said; Mohamed S Al-Balushi
Journal:  Sultan Qaboos Univ Med J       Date:  2019-09-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.